Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development
In: Beneficial MicrobesSearch for other papers by N. Mojgani in
Current site
Google Scholar
Search for other papers by Y. Shahali in
Current site
Google Scholar
Search for other papers by M. Dadar in
Current site
Google Scholar
Vaccination is one of the most important prevention tools providing protection against infectious diseases especially in children below the age of five. According to estimates, more than 5 million lives are saved annually by the implementation of six standard vaccines, including diphtheria, hepatitis B, Haemophilus influenza type b, polio, tetanus and yellow fever. Despite these efforts, we are faced with challenges in developing countries where increasing population and increasing disease burden and difficulties in vaccine coverage and delivery cause significant morbidity and mortality. Additionally, the high cost of these vaccines is also one of the causes for inappropriate and inadequate vaccinations in these regions. Thus, developing cost-effective vaccine strategies that could provide a stronger immune response with reduced vaccination schedules and maximum coverage is of critical importance. In last decade, different approaches have been investigated; among which live bacterial vaccines have been the focus of attention. In this regard, probiotic lactic acid bacteria have been extensively studied as safe and effective vaccine candidates. These microorganisms represent the largest group of probiotic bacteria in the intestine and are generally recognised as safe (GRAS) bacteria. They have also attracted attention due to their immunomodulatory actions and their effective role as novel vaccine adjuvants. A significant property of these bacteria is their ability to mimic natural infections, while intrinsically possessing mucosal adjuvant properties. Additionally, as live bacterial vaccines are administered orally or nasally, they have higher acceptance and better safety, but also avoid the risk of contamination due to needles and syringes. In this review, we emphasise the role of probiotic Lactobacillus strains as putative oral vaccine carriers and novel vaccine adjuvants.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Adel, M., El-Sayed, A.-F.M., Yeganeh, S., Dadar, M. and Giri, S.S., 2017. Effect of potential probiotic Lactococcus lactis subsp. lactis on growth performance, intestinal microbiota, digestive enzyme activities, and disease resistance of Litopenaeus vannamei. Probiotics and Antimicrobial Proteins 9: 150-156.
'Effect of potential probiotic Lactococcus lactis subsp. lactis on growth performance, intestinal microbiota, digestive enzyme activities, and disease resistance of Litopenaeus vannamei ' () 9 Probiotics and Antimicrobial Proteins : 150 -156 .
-
Ahmadi, E., Alizadeh-Navaei, R. and Rezai, M.S., 2015. Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis. Caspian Journal of Internal Medicine 6: 187.
'Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis ' () 6 Caspian Journal of Internal Medicine : 187 .
-
Akira, S., Takeda, K. and Kaisho, T., 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2: 675.
'Toll-like receptors: critical proteins linking innate and acquired immunity ' () 2 Nature Immunology : 675 .
-
Aldovini, A. and Young, R.A., 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351: 479.
'Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines ' () 351 Nature : 479 .
-
Allen, S.J., Jordan, S., Storey, M., Thornton, C.A., Gravenor, M.B., Garaiova, I., Plummer, S.F., Wang, D. and Morgan, G., 2014. Probiotics in the prevention of eczema: a randomised controlled trial. Archives of Disease in Childhood 99: 1014-1019.
'Probiotics in the prevention of eczema: a randomised controlled trial ' () 99 Archives of Disease in Childhood : 1014 -1019 .
-
Amdekar, S., Dwivedi, D., Roy, P., Kushwah, S. and Singh, V., 2010. Probiotics: multifarious oral vaccine against infectious traumas. FEMS Immunology and Medical Microbiology 58: 299-306.
'Probiotics: multifarious oral vaccine against infectious traumas ' () 58 FEMS Immunology and Medical Microbiology : 299 -306 .
-
Anand, A., Sato, M. and Aoyagi, H., 2019. Screening of phosphate-accumulating probiotics for potential use in chronic kidney disorder. Food Science and Technology Research 25: 89-96.
'Screening of phosphate-accumulating probiotics for potential use in chronic kidney disorder ' () 25 Food Science and Technology Research : 89 -96 .
-
Anukam, K.C., Osazuwa, E.O., Osadolor, H.B., Bruce, A.W. and Reid, G., 2008. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. Journal of Clinical Gastroenterology 42: 239-243.
'Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients ' () 42 Journal of Clinical Gastroenterology : 239 -243 .
-
Arunachalam, K., Gill, H. and Chandra, R., 2000. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). European Journal of Clinical Nutrition 54: 263.
'Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) ' () 54 European Journal of Clinical Nutrition : 263 .
-
Ashraf, R. and Shah, N.P., 2014. Immune system stimulation by probiotic microorganisms. Critical Reviews in Food Science and Nutrition 54: 938-956.
'Immune system stimulation by probiotic microorganisms ' () 54 Critical Reviews in Food Science and Nutrition : 938 -956 .
-
Azcárate-Peril, M.A., Sikes, M. and Bruno-Bárcena, J.M., 2011. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? American Journal of Physiology – Gastrointestinal and Liver Physiology 301: G401-G424.
'The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? ' () 301 American Journal of Physiology – Gastrointestinal and Liver Physiology : G401 -G424 .
-
Bilyy, R., Paryzhak, S., Turcheniuk, K., Dumych, T., Barras, A., Boukherroub, R., Wang, F., Yushin, G. and Szunerits, S., 2019. Aluminum oxide nanowires as safe and effective adjuvants for next-generation vaccines. Materials Today 22: 58-66.
'Aluminum oxide nanowires as safe and effective adjuvants for next-generation vaccines ' () 22 Materials Today : 58 -66 .
-
Bisanz, J.E., Enos, M.K., PrayGod, G., Seney, S., Macklaim, J.M., Chilton, S., Willner, D., Knight, R., Fusch, C. and Fusch, G., 2015. Microbiota at multiple body sites during pregnancy in a rural Tanzanian population and effects of Moringa-supplemented probiotic yogurt. Applied and Environmental Microbiology 81: 4965-4975.
'Microbiota at multiple body sites during pregnancy in a rural Tanzanian population and effects of Moringa-supplemented probiotic yogurt ' () 81 Applied and Environmental Microbiology : 4965 -4975 .
-
Boge, T., Rémigy, M., Vaudaine, S., Tanguy, J., Bourdet-Sicard, R. and Van der Werf, S., 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27: 5677-5684.
'A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials ' () 27 Vaccine : 5677 -5684 .
-
Bondanza, A., Zimmermann, V.S., Dell’Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M.G., Manfredi, A.A. and Rovere-Querini, P., 2003. Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. Journal of Immunology 170: 24-27.
'Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells ' () 170 Journal of Immunology : 24 -27 .
-
Bosch, M., Mendez, M., Perez, M., Farran, A., Fuentes, M. and Cune, J., 2012. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutricion Hospitalaria 27: 504-509.
'Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly ' () 27 Nutricion Hospitalaria : 504 -509 .
-
Bouvier, M., Meance, S., Bouley, C., Berta, J.-L. and Grimaud, J.-C., 2001. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans. Bioscience and Microflora 20: 43-48.
'Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans ' () 20 Bioscience and Microflora : 43 -48 .
-
Bunout, D., Hirsch, S., De la Maza, M.P., Munoz, C., Haschke, F., Steenhout, P., Klassen, P., Barrera, G., Gattas, V. and Petermann, M., 2002. Effects of prebiotics on the immune response to vaccination in the elderly. Journal of Parenteral and Enteral Nutrition 26: 372-376.
'Effects of prebiotics on the immune response to vaccination in the elderly ' () 26 Journal of Parenteral and Enteral Nutrition : 372 -376 .
-
Cervin, A.U., 2018. The potential for topical probiotic treatment of chronic rhinosinusitis, a personal perspective. Frontiers in Cellular and Infection Microbiology 7: 530.
'The potential for topical probiotic treatment of chronic rhinosinusitis, a personal perspective ' () 7 Frontiers in Cellular and Infection Microbiology : 530 .
-
Chun, T.-W. and Fauci, A.S., 2012. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS 26: 1261-1268.
'HIV reservoirs: pathogenesis and obstacles to viral eradication and cure ' () 26 AIDS : 1261 -1268 .
-
Collins, S.M. and Bercik, P., 2009. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003-2014.
'The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease ' () 136 Gastroenterology : 2003 -2014 .
-
Cremon, C., Barbaro, M.R., Ventura, M. and Barbara, G., 2018. Pre-and probiotic overview. Current Opinion in Pharmacology 43: 87-92.
'Pre-and probiotic overview ' () 43 Current Opinion in Pharmacology : 87 -92 .
-
D’Angelo, C., Reale, M. and Costantini, E., 2017. Microbiota and probiotics in health and HIV infection. Nutrients 9: 615.
'Microbiota and probiotics in health and HIV infection ' () 9 Nutrients : 615 .
-
Davidson, L.E., Fiorino, A.-M., Snydman, D.R. and Hibberd, P.L., 2011. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. European Journal of Clinical Nutrition 65: 501.
'Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial ' () 65 European Journal of Clinical Nutrition : 501 .
-
De Vrese, M., Rautenberg, P., Laue, C., Koopmans, M., Herremans, T. and Schrezenmeir, J., 2005. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. European Journal of Nutrition 44: 406-413.
'Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination ' () 44 European Journal of Nutrition : 406 -413 .
-
Del Rio, B., Redruello, B., Fernandez, M., Martin, M.C., Ladero, V. and Alvarez, M.A., 2018. Lactic acid bacteria as a live delivery system for the in situ production of nanobodies in the human gastrointestinal tract. Frontiers in Microbiology 9: 3179.
'Lactic acid bacteria as a live delivery system for the in situ production of nanobodies in the human gastrointestinal tract ' () 9 Frontiers in Microbiology : 3179 .
-
Derrien, M., Van Passel, M.W., Van de Bovenkamp, J.H., Schipper, R., De Vos, W. and Dekker, J., 2010. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1: 254-268.
'Mucin-bacterial interactions in the human oral cavity and digestive tract ' () 1 Gut Microbes : 254 -268 .
-
Detmer, A. and Glenting, J., 2006. Live bacterial vaccines – a review and identification of potential hazards. Microbial Cell Factories 5: 23.
'Live bacterial vaccines – a review and identification of potential hazards ' () 5 Microbial Cell Factories : 23 .
-
Di Fabio, S., Medaglini, D., Rush, C., Corrias, F., Panzini, G., Pace, M., Verani, P., Pozzi, G. and Titti, F., 1998. Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. Vaccine 16: 485-492.
'Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens ' () 16 Vaccine : 485 -492 .
-
Duerr, A., Wasserheit, J.N. and Corey, L., 2006. HIV vaccines: new frontiers in vaccine development. Clinical Infectious Diseases 43: 500-511.
'HIV vaccines: new frontiers in vaccine development ' () 43 Clinical Infectious Diseases : 500 -511 .
-
Ehreth, J., 2003. The global value of vaccination. Vaccine 21: 596-600.
'The global value of vaccination ' () 21 Vaccine : 596 -600 .
-
Fang, H., Elina, T., Heikki, A. and Seppo, S., 2000. Modulation of humoral immune response through probiotic intake. FEMS Immunology and Medical Microbiology 29: 47-52.
'Modulation of humoral immune response through probiotic intake ' () 29 FEMS Immunology and Medical Microbiology : 47 -52 .
-
Fava, F. and Danese, S., 2011. Intestinal microbiota in inflammatory bowel disease: friend of foe? World Journal of Gastroenterology 17: 557.
'Intestinal microbiota in inflammatory bowel disease: friend of foe? ' () 17 World Journal of Gastroenterology : 557 .
-
Ferreccio, C., Ortiz, E., Cryz, S. and Levine, M., 1990. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. The Lancet 336: 891-894.
'Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial ' () 336 The Lancet : 891 -894 .
-
Ferreira, R.B., Antunes, L.C.M. and Finlay, B.B., 2010. Should the human microbiome be considered when developing vaccines? PLoS Pathogens 6: e1001190.
'Should the human microbiome be considered when developing vaccines? ' () 6 PLoS Pathogens : e1001190 .
-
Foligne, B., Zoumpopoulou, G., Dewulf, J., Younes, A.B., Chareyre, F., Sirard, J.-C., Pot, B. and Grangette, C., 2007. A key role of dendritic cells in probiotic functionality. PLoS ONE 2: e313.
'A key role of dendritic cells in probiotic functionality ' () 2 PLoS ONE : e313 .
-
Frei, R., Akdis, M. and O’Mahony, L., 2015. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Current Opinion in Gastroenterology 31: 153-158.
'Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence ' () 31 Current Opinion in Gastroenterology : 153 -158 .
-
Freiberger, S.N., Leuthard, D.S., Duda, A., Contassot, E., Thallmair, M., Kündig, T.M. and Johansen, P., 2018. Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice. European Journal of Pharmaceutical Sciences 115: 362-368.
'Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice ' () 115 European Journal of Pharmaceutical Sciences : 362 -368 .
-
Fuller, R., 1992. History and development of probiotics, probiotics. Springer, Cham, Switzerland, pp. 1-8.
'History and development of probiotics, probiotics ' () : 1 -8 .
-
Galdeano, C.M. and Perdigon, G., 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clinical and Vaccine Immunology 13: 219-226.
'The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity ' () 13 Clinical and Vaccine Immunology : 219 -226 .
-
Galdeano, C.M., Cazorla, S.I., Dumit, J.M.L., Vélez, E. and Perdigón, G., 2019. beneficial effects of probiotic consumption on the immune system. Annals of Nutrition and Metabolism 74: 115-124.
'beneficial effects of probiotic consumption on the immune system ' () 74 Annals of Nutrition and Metabolism : 115 -124 .
-
Glenting, J., Poulsen, L.K., Kato, K., Madsen, S.M., Frøkiær, H., Wendt, C. and Sørensen, H.W., 2007. Production of recombinant peanut allergen Ara h 2 using Lactococcus lactis. Microbial Cell Factories 6: 28.
'Production of recombinant peanut allergen Ara h 2 using Lactococcus lactis ' () 6 Microbial Cell Factories : 28 .
-
Goronzy, J.J. and Weyand, C.M., 2013. Understanding immunosenescence to improve responses to vaccines. Nature Immunology 14: 428.
'Understanding immunosenescence to improve responses to vaccines ' () 14 Nature Immunology : 428 .
-
Gram, G.J., Fomsgaard, A., Thorn, M., Madsen, S.M. and Glenting, J., 2007. Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120. Genetic Vaccines and Therapy 5: 3.
'Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120 ' () 5 Genetic Vaccines and Therapy : 3 .
-
Greenwood, R., Raynard, M., Kodeih, F., Micelotta, E.R. and Lounsbury, M., 2011. Institutional complexity and organizational responses. Academy of Management Annals 5: 317-371.
'Institutional complexity and organizational responses ' () 5 Academy of Management Annals : 317 -371 .
-
Guandalini, S., 2008. Probiotics for children with diarrhea: an update. Journal of Clinical Gastroenterology 42: S53-S57.
'Probiotics for children with diarrhea: an update ' () 42 Journal of Clinical Gastroenterology : S53 -S57 .
-
Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A. and De Sousa, J.S., 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition 30: 54-60.
'Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial ' () 30 Journal of Pediatric Gastroenterology and Nutrition : 54 -60 .
-
Guarner, F. and Schaafsma, G., 1998. Probiotics. International Journal of Food Microbiology 39: 237-238.
'Probiotics ' () 39 International Journal of Food Microbiology : 237 -238 .
-
Haase, A.T., 2005. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Reviews Immunology 5: 783.
'Perils at mucosal front lines for HIV and SIV and their hosts ' () 5 Nature Reviews Immunology : 783 .
-
Hanniffy, S.B., Carter, A.T., Hitchin, E. and Wells, J.M., 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. The Journal of Infectious Diseases 195: 185-193.
'Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection ' () 195 The Journal of Infectious Diseases : 185 -193 .
-
Heron, S.E. and Elahi, S., 2017. HIV infection and compromised mucosal immunity: oral manifestations and systemic inflammation. Frontiers in Immunology 8: 241.
'HIV infection and compromised mucosal immunity: oral manifestations and systemic inflammation ' () 8 Frontiers in Immunology : 241 .
-
Hoseinifar, S.H., Dadar, M. and Ringø, E., 2017. Modulation of nutrient digestibility and digestive enzyme activities in aquatic animals: the functional feed additives scenario. Aquaculture Research 48: 3987-4000.
'Modulation of nutrient digestibility and digestive enzyme activities in aquatic animals: the functional feed additives scenario ' () 48 Aquaculture Research : 3987 -4000 .
-
Isolauri, E., Arvola, T., Sütas, Y., Moilanen, E. and Salminen, S., 2000. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 30: 1605-1610.
'Probiotics in the management of atopic eczema ' () 30 Clinical and Experimental Allergy : 1605 -1610 .
-
Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M. and Vesikari, T., 1995. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13: 310-312.
'Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG ' () 13 Vaccine : 310 -312 .
-
Jandhyala, S.M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M. and Reddy, D.N., 2015. Role of the normal gut microbiota. World Journal of Gastroenterology 21: 8787.
'Role of the normal gut microbiota ' () 21 World Journal of Gastroenterology : 8787 .
-
Jiang, B., Li, Z., Ou, B., Duan, Q. and Zhu, G., 2019. Targeting ideal oral vaccine vectors based on probiotics: a systematical view. Applied Microbiology and Biotechnology 103: 3941-3953.
'Targeting ideal oral vaccine vectors based on probiotics: a systematical view ' () 103 Applied Microbiology and Biotechnology : 3941 -3953 .
-
Johansson, K.A. and Norheim, O.F., 2011. Problems with prioritization: exploring ethical solutions to inequalities in HIV care. American Journal of Bioethics 11: 32-40.
'Problems with prioritization: exploring ethical solutions to inequalities in HIV care ' () 11 American Journal of Bioethics : 32 -40 .
-
Kajikawa, A., Zhang, L., Long, J., Nordone, S., Stoeker, L., LaVoy, A., Bumgardner, S., Klaenhammer, T. and Dean, G., 2012. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clinical and Vaccine Immunology 19: 1374-1381.
'Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery ' () 19 Clinical and Vaccine Immunology : 1374 -1381 .
-
Kałużna-Czaplińska, J., Gątarek, P., Chartrand, M.S., Dadar, M. and Bjørklund, G., 2017. Is there a relationship between intestinal microbiota, dietary compounds, and obesity? Trends in Food Science and Technology 70: 105-113.
'Is there a relationship between intestinal microbiota, dietary compounds, and obesity? ' () 70 Trends in Food Science and Technology : 105 -113 .
-
Kassayova, M., Bobrov, N., Strojný, L., Kiskova, T., Mikeš, J., Demečková, V., Orendáš, P., Bojkova, B., Péč, M. and Kubatka, P., 2014. Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis. Anticancer Research 34: 4969-4975.
'Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis ' () 34 Anticancer Research : 4969 -4975 .
-
Kawashima, T., Ikari, N., Kouchi, T., Kowatari, Y., Kubota, Y., Shimojo, N. and Tsuji, N.M., 2018. The molecular mechanism for activating IgA production by Pediococcus acidilactici K15 and the clinical impact in a randomized trial. Scientific Reports 8: 5065.
'The molecular mechanism for activating IgA production by Pediococcus acidilactici K15 and the clinical impact in a randomized trial ' () 8 Scientific Reports : 5065 .
-
Korik, L., Liubimova, L. and Tovstoles, K., 1968. Immediate and remote results of the treatment of male trichomonas infections with trichomonas vaccine. Vestnik Dermatologii i Venerologii 42: 80-84.
'Immediate and remote results of the treatment of male trichomonas infections with trichomonas vaccine ' () 42 Vestnik Dermatologii i Venerologii : 80 -84 .
-
Kukkonen, K., Kuitunen, M., Haahtela, T., Korpela, R., Poussa, T. and Savilahti, E., 2010. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatric Allergy and Immunology 21: 67-73.
'High intestinal IgA associates with reduced risk of IgE-associated allergic diseases ' () 21 Pediatric Allergy and Immunology : 67 -73 .
-
Kukkonen, K., Nieminen, T., Poussa, T., Savilahti, E. and Kuitunen, M., 2006. Effect of probiotics on vaccine antibody responses in infancy – a randomized placebo-controlled double-blind trial. Pediatric Allergy and Immunology 17: 416-421.
'Effect of probiotics on vaccine antibody responses in infancy – a randomized placebo-controlled double-blind trial ' () 17 Pediatric Allergy and Immunology : 416 -421 .
-
La Fata, G., Weber, P. and Mohajeri, M.H., 2018. Probiotics and the gut immune system: indirect regulation. Probiotics and Antimicrobial Proteins 10: 11-21.
'Probiotics and the gut immune system: indirect regulation ' () 10 Probiotics and Antimicrobial Proteins : 11 -21 .
-
Li, Y.-T., Xu, H., Ye, J.-Z., Wu, W.-R., Shi, D., Fang, D.-Q., Liu, Y. and Li, L.-J., 2019. Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: a systematic review with meta-analysis. World Journal of Gastroenterology 25: 4999.
'Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: a systematic review with meta-analysis ' () 25 World Journal of Gastroenterology : 4999 .
-
Licciardi, P.V. and Tang, M.L., 2011. Vaccine adjuvant properties of probiotic bacteria. Discovery Medicine 12: 525-533.
'Vaccine adjuvant properties of probiotic bacteria ' () 12 Discovery Medicine : 525 -533 .
-
Lilly, D.M. and Stillwell, R.H., 1965. Probiotics: growth-promoting factors produced by microorganisms. Science 147: 747-748.
'Probiotics: growth-promoting factors produced by microorganisms ' () 147 Science : 747 -748 .
-
Link-Amster, H., Rochat, F., Saudan, K., Mignot, O. and Aeschlimann, J., 1994. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunology and Medical Microbiology 10: 55-63.
'Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake ' () 10 FEMS Immunology and Medical Microbiology : 55 -63 .
-
Lorea Baroja, M., Kirjavainen, P., Hekmat, S. and Reid, G., 2007. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clinical and Experimental Immunology 149: 470-479.
'Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients ' () 149 Clinical and Experimental Immunology : 470 -479 .
-
Maidens, C., Childs, C., Przemska, A., Dayel, I.B. and Yaqoob, P., 2013. Modulation of vaccine response by concomitant probiotic administration. British Journal of Clinical Pharmacology 75: 663-670.
'Modulation of vaccine response by concomitant probiotic administration ' () 75 British Journal of Clinical Pharmacology : 663 -670 .
-
Matsuda, F., Chowdhury, M.I., Saha, A., Asahara, T., Nomoto, K., Tarique, A.A., Ahmed, T., Nishibuchi, M., Cravioto, A. and Qadri, F., 2011. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 29: 1855-1888.
'Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age ' () 29 Vaccine : 1855 -1888 .
-
Medina, M., Villena, J., Salva, S., Vintiñi, E., Langella, P. and Alvarez, S., 2008a. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiology and Immunology 52: 399-409.
'Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae ' () 52 Microbiology and Immunology : 399 -409 .
-
Medina, M., Villena, J., Vintiñi, E., Hebert, E.M., Raya, R. and Alvarez, S., 2008b. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infection and Immunity 76: 2696-2705.
'Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice ' () 76 Infection and Immunity : 2696 -2705 .
-
Mercenier, A., Muller-Alouf, H. and Grangette, C., 2000. Lactic acid bacteria as live vaccines. Current Issues in Molecular Biology 2: 17-26.
'Lactic acid bacteria as live vaccines ' () 2 Current Issues in Molecular Biology : 17 -26 .
-
Mohan, T., Verma, P. and Rao, D.N., 2013. Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian Journal of Medical Research 138: 779.
'Novel adjuvants & delivery vehicles for vaccines development: a road ahead ' () 138 Indian Journal of Medical Research : 779 .
-
Monto, A.S., Ansaldi, F., Aspinall, R., McElhaney, J.E., Montaño, L.F., Nichol, K.L., Puig-Barberà, J., Schmitt, J. and Stephenson, I., 2009. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 27: 5043-5053.
'Influenza control in the 21st century: optimizing protection of older adults ' () 27 Vaccine : 5043 -5053 .
-
Morelli, L. and Capurso, L., 2012. FAO/WHO guidelines on probiotics: 10 years later. Journal of Clinical Gastroenterology 46: S1-S2.
'FAO/WHO guidelines on probiotics: 10 years later ' () 46 Journal of Clinical Gastroenterology : S1 -S2 .
-
Morita, J.Y., Zell, E.R., Danila, R., Farley, M.M., Hadler, J., Harrison, L.H., Lefkowitz, L., Reingold, A., Kupronis, B.A. and Schuchat, A., 2002. Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clinical Infectious Diseases 35: 420-427.
'Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community ' () 35 Clinical Infectious Diseases : 420 -427 .
-
Mowat, A.M. and Viney, J.L., 1997. The anatomical basis of intestinal immunity. Immunological Reviews 156: 145-166.
'The anatomical basis of intestinal immunity ' () 156 Immunological Reviews : 145 -166 .
-
Mullié, C., Yazourh, A., Thibault, H., Odou, M.-F., Singer, E., Kalach, N., Kremp, O. and Romond, M.-B., 2004. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatric Research 56: 791.
'Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial ' () 56 Pediatric Research : 791 .
-
Namba, K., Hatano, M., Yaeshima, T., Takase, M. and Suzuki, K., 2010. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Bioscience, Biotechnology, and Biochemistry 74: 939-945.
'Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly ' () 74 Bioscience, Biotechnology, and Biochemistry : 939 -945 .
-
Neto, M.P.C., De Souza Aquino, J., Da Silva, L.D.F.R., De Oliveira Silva, R., De Lima Guimaraes, K.S., De Oliveira, Y., De Souza, E.L., Magnani, M., Vidal, H. and De Brito Alves, J.L., 2018. Gut microbiota and probiotics intervention: a potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? Pharmacological Research 130: 152-163.
'Gut microbiota and probiotics intervention: a potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease? ' () 130 Pharmacological Research : 152 -163 .
-
Nikolich-Žugich, J., 2018. The twilight of immunity: emerging concepts in aging of the immune system. Nature Immunology 19: 10-19.
'The twilight of immunity: emerging concepts in aging of the immune system ' () 19 Nature Immunology : 10 -19 .
-
Oak, S.J. and Jha, R., 2019. The effects of probiotics in lactose intolerance: a systematic review. Critical Reviews in Food Science and Nutrition 59: 1675-1683.
'The effects of probiotics in lactose intolerance: a systematic review ' () 59 Critical Reviews in Food Science and Nutrition : 1675 -1683 .
-
Ohland, C.L. and MacNaughton, W.K., 2010. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology – Gastrointestinal and Liver Physiology 298: G807-G819.
'Probiotic bacteria and intestinal epithelial barrier function ' () 298 American Journal of Physiology – Gastrointestinal and Liver Physiology : G807 -G819 .
-
Okoye, A.A. and Picker, L.J., 2013. CD 4+ T-cell depletion in HIV infection: mechanisms of immunological failure. Immunological Reviews 254: 54-64.
'CD 4+ T-cell depletion in HIV infection: mechanisms of immunological failure ' () 254 Immunological Reviews : 54 -64 .
-
Olivares, M., Díaz-Ropero, M.P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., Rodríguez, J.M. and Xaus, J., 2007. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23: 254-260.
'Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination ' () 23 Nutrition : 254 -260 .
-
Oliveira, M.L.S., Arêas, A.P.M., Campos, I.B., Monedero, V., Perez-Martínez, G., Miyaji, E.N., Leite, L.C.C., Aires, K.A. and Ho, P.L., 2006. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes and Infection 8: 1016-1024.
'Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A ' () 8 Microbes and Infection : 1016 -1024 .
-
Paineau, D., Carcano, D., Leyer, G., Darquy, S., Alyanakian, M.-A., Simoneau, G., Bergmann, J.-F., Brassart, D., Bornet, F. and Ouwehand, A.C., 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunology and Medical Microbiology 53: 107-113.
'Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial ' () 53 FEMS Immunology and Medical Microbiology : 107 -113 .
-
Pandey, K.R., Naik, S.R. and Vakil, B.V., 2015. Probiotics, prebiotics and synbiotics – a review. Journal of Food Science and Technology 52: 7577-7587.
'Probiotics, prebiotics and synbiotics – a review ' () 52 Journal of Food Science and Technology : 7577 -7587 .
-
Pasquale, A.D., Preiss, S., Silva, F.T.D. and Garçon, N., 2015. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines 3: 320-343.
'Vaccine adjuvants: from 1920 to 2015 and beyond ' () 3 Vaccines : 320 -343 .
-
Perdigón, G. and Alvarez, S., 1992. Probiotics and the immune state, probiotics. Springer, Cham, Switzerland, pp. 145-180.
'Probiotics and the immune state, probiotics ' () : 145 -180 .
-
Peterson, C.T., Sharma, V., Elmén, L. and Peterson, S.N., 2015. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clinical and Experimental Immunology 179: 363-377.
'Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota ' () 179 Clinical and Experimental Immunology : 363 -377 .
-
Petrova, M.I., Van den Broek, M., Balzarini, J., Vanderleyden, J. and Lebeer, S., 2013. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiology Reviews 37: 762-792.
'Vaginal microbiota and its role in HIV transmission and infection ' () 37 FEMS Microbiology Reviews : 762 -792 .
-
Ramasamy, R., Yasawardena, S., Zomer, A., Venema, G., Kok, J. and Leenhouts, K., 2006. Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24: 3900-3908.
'Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations ' () 24 Vaccine : 3900 -3908 .
-
Reed, S.G., Bertholet, S., Coler, R.N. and Friede, M., 2009. New horizons in adjuvants for vaccine development. Trends in Immunology 30: 23-32.
'New horizons in adjuvants for vaccine development ' () 30 Trends in Immunology : 23 -32 .
-
Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J. and Henning, B., 2001. Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology 30: 49-52.
'Oral probiotics can resolve urogenital infections ' () 30 FEMS Immunology and Medical Microbiology : 49 -52 .
-
Reid, G., Jass, J., Sebulsky, M.T. and McCormick, J.K., 2003. Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews 16: 658-672.
'Potential uses of probiotics in clinical practice ' () 16 Clinical Microbiology Reviews : 658 -672 .
-
Reiprich, S., Gundlach, B.R., Fleckenstein, B. and Uberla, K., 1997. Replication-competent chimeric lenti-oncovirus with expanded host cell tropism. Journal of Virology 71: 3328-3331.
'Replication-competent chimeric lenti-oncovirus with expanded host cell tropism ' () 71 Journal of Virology : 3328 -3331 .
-
Rizzardini, G., Eskesen, D., Calder, P.C., Capetti, A., Jespersen, L. and Clerici, M., 2012. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition 107: 876-884.
'Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp ' () 107 British Journal of Nutrition : 876 -884 .
-
Robertson, J.S., 1994. Safety considerations for nucleic acid vaccines. Vaccine 12: 1526-1528.
'Safety considerations for nucleic acid vaccines ' () 12 Vaccine : 1526 -1528 .
-
Rolfe, R.D., 2000. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition 130: 396S-402S.
'The role of probiotic cultures in the control of gastrointestinal health ' () 130 Journal of Nutrition : 396S -402S .
-
Rosshart, S.P., Vassallo, B.G., Angeletti, D., Hutchinson, D.S., Morgan, A.P., Takeda, K., Hickman, H.D., McCulloch, J.A., Badger, J.H. and Ajami, N.J., 2017. Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell 171: 1015-1028.
'Wild mouse gut microbiota promotes host fitness and improves disease resistance ' () 171 Cell : 1015 -1028 .
-
Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M. and Margolles, A., 2017. Probiotics, gut microbiota, and their influence on host health and disease. Molecular Nutrition and Food Research 61: 1600240.
'Probiotics, gut microbiota, and their influence on host health and disease ' () 61 Molecular Nutrition and Food Research : 1600240 .
-
Sartor, R.B., 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
'Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics ' () 126 Gastroenterology : 1620 -1633 .
-
Scagnolari, C., Monteleone, K., Selvaggi, C., Pierangeli, A., D’Ettorre, G., Mezzaroma, I., Turriziani, O., Gentile, M., Vullo, V. and Antonelli, G., 2016. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response. Immunobiology 221: 282-290.
'ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response ' () 221 Immunobiology : 282 -290 .
-
Sharma, A., 2019. Importance of probiotics in cancer prevention and treatment. In: Viswanath, B., Fedor, J., Versteeg-Buschman, L. and Bennett, T. (eds.) Recent developments in applied microbiology and biochemistry. Elsevier, San Diego, CA, USA, pp. 33-45.
'Importance of probiotics in cancer prevention and treatment ' () : 33 -45 .
-
Sleator, R.D., 2010. Probiotic therapy-recruiting old friends to fight new foes. Gut Pathogens 2: 5.
'Probiotic therapy-recruiting old friends to fight new foes ' () 2 Gut Pathogens : 5 .
-
Soh, S.E., Ong, D.Q.R., Gerez, I., Zhang, X., Chollate, P., Shek, L.P.-C., Lee, B.W. and Aw, M., 2010. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 28: 2577-2579.
'Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination ' () 28 Vaccine : 2577 -2579 .
-
Steidler, L., 2003. Genetically engineered probiotics. Best Practice and Research Clinical Gastroenterology 17: 861-876.
'Genetically engineered probiotics ' () 17 Best Practice and Research Clinical Gastroenterology : 861 -876 .
-
Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J.P. and Remaut, E., 2003. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotechnology 21: 785.
'Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 ' () 21 Nature Biotechnology : 785 .
-
Taylor, A., Hale, J., Wiltschut, J., Lehmann, H., Dunstan, J. and Prescott, S., 2006. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clinical and Experimental Allergy 36: 1227-1235.
'Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses ' () 36 Clinical and Experimental Allergy : 1227 -1235 .
-
Tong, C.Y.W., 2019. Tutorial topics in infection for the combined infection training programme. Oxford University Press, New York, NY, USA.
'Tutorial topics in infection for the combined infection training programme ' () .
-
Trachootham, D., Chupeerach, C., Tuntipopipat, S., Pathomyok, L., Boonnak, K., Praengam, K., Promkam, C. and Santivarangkna, C., 2017. Drinking fermented milk containing Lactobacillus paracasei 431 (IMULUS™) improves immune response against H1N1 and cross-reactive H3N2 viruses after influenza vaccination: a pilot randomized triple-blinded placebo-controlled trial. Journal of Functional Foods 33: 1-10.
'Drinking fermented milk containing Lactobacillus paracasei 431 (IMULUS™) improves immune response against H1N1 and cross-reactive H3N2 viruses after influenza vaccination: a pilot randomized triple-blinded placebo-controlled trial ' () 33 Journal of Functional Foods : 1 -10 .
-
Tuomola, E.M., Ouwehand, A.C. and Salminen, S.J., 1999. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunology and Medical Microbiology 26: 137-142.
'The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus ' () 26 FEMS Immunology and Medical Microbiology : 137 -142 .
-
Valdez, Y., Brown, E.M. and Finlay, B.B., 2014. Influence of the microbiota on vaccine effectiveness. Trends in Immunology 35: 526-537.
'Influence of the microbiota on vaccine effectiveness ' () 35 Trends in Immunology : 526 -537 .
-
Van Hoang, V., Ochi, T., Kurata, K., Arita, Y., Ogasahara, Y. and Enomoto, K., 2018. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis. Applied Microbiology and Biotechnology 102: 261-268.
'Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis ' () 102 Applied Microbiology and Biotechnology : 261 -268 .
-
VandenDriessche, T., Collen, D. and Chuah, M.K., 2003. Biosafety of onco-retroviral vectors. Current Gene Therapy 3: 501-515.
'Biosafety of onco-retroviral vectors ' () 3 Current Gene Therapy : 501 -515 .
-
Varankovich, N.V., Nickerson, M.T. and Korber, D.R., 2015. Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Frontiers in Microbiology 6: 685.
'Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases ' () 6 Frontiers in Microbiology : 685 .
-
Vekemans, J. and Ballou, W.R., 2008. Plasmodium falciparum malaria vaccines in development. Expert Review of Vaccines 7: 223-240.
'Plasmodium falciparum malaria vaccines in development ' () 7 Expert Review of Vaccines : 223 -240 .
-
Villena, J., Barbieri, N., Salva, S., Herrera, M. and Alvarez, S., 2009. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiology and Immunology 53: 636-646.
'Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei ' () 53 Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiology and Immunology : 636 -646 .
-
Villena, J., Medina, M., Racedo, S. and Alvarez, S., 2010. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis. Journal of Microbiology, Immunology and Infection 43: 1-10.
'Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis ' () 43 Journal of Microbiology, Immunology and Infection : 1 -10 .
-
Villena, J., Medina, M., Vintiñi, E. and Alvarez, S., 2008. Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Canadian Journal of Microbiology 54: 630-638.
'Stimulation of respiratory immunity by oral administration of Lactococcus lactis ' () 54 Canadian Journal of Microbiology : 630 -638 .
-
Vlasova, A.N., Takanashi, S., Miyazaki, A., Rajashekara, G. and Saif, L.J., 2019. How the gut microbiome regulates host immune responses to viral vaccines. Current Opinion in Virology 37: 16-25.
'How the gut microbiome regulates host immune responses to viral vaccines ' () 37 Current Opinion in Virology : 16 -25 .
-
West, C.E., Gothefors, L., Granström, M., Käyhty, H., Hammarström, M.L.K. and Hernell, O., 2008. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatric Allergy and Immunology 19: 53-60.
'Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines ' () 19 Pediatric Allergy and Immunology : 53 -60 .
-
Xin, K.-Q., Hoshino, Y., Toda, Y., Igimi, S., Kojima, Y., Jounai, N., Ohba, K., Kushiro, A., Kiwaki, M. and Hamajima, K., 2003. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223-228.
'Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env ' () 102 Blood : 223 -228 .
-
Yan, F. and Polk, D., 2011. Probiotics and immune health. Current Opinion in Gastroenterology 27: 496.
'Probiotics and immune health ' () 27 Current Opinion in Gastroenterology : 496 .
-
Youngster, I., Kozer, E., Lazarovitch, Z., Broide, E. and Goldman, M., 2011. Probiotics and the immunological response to infant vaccinations: a prospective, placebo-controlled pilot study. Archives of Disease in Childhood 96: 345-349.
'Probiotics and the immunological response to infant vaccinations: a prospective, placebo-controlled pilot study ' () 96 Archives of Disease in Childhood : 345 -349 .
-
Yousefi, B., Eslami, M., Ghasemian, A., Kokhaei, P., Salek Farrokhi, A. and Darabi, N., 2019. Probiotics importance and their immunomodulatory properties. Journal of Cellular Physiology 234: 8008-8018.
'Probiotics importance and their immunomodulatory properties ' () 234 Journal of Cellular Physiology : 8008 -8018 .
-
Zhang, Z.-H., Jiang, P.-H., Li, N.-J., Shi, M. and Huang, W., 2005. Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-119. World Journal of Gastroenterology 11: 6975.
'Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-119 ' () 11 World Journal of Gastroenterology : 6975 .
-
Zimmermann, P. and Curtis, N., 2018. The influence of probiotics on vaccine responses – a systematic review. Vaccine 36: 207-213.
'The influence of probiotics on vaccine responses – a systematic review ' () 36 Vaccine : 207 -213 .
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 898 | 665 | 97 |
| Full Text Views | 26 | 10 | 1 |
| PDF Views & Downloads | 33 | 15 | 0 |
Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development
In: Beneficial MicrobesSearch for other papers by N. Mojgani in
Current site
Google Scholar
PubMed
Search for other papers by Y. Shahali in
Current site
Google Scholar
PubMed
Search for other papers by M. Dadar in
Current site
Google Scholar
PubMed
Vaccination is one of the most important prevention tools providing protection against infectious diseases especially in children below the age of five. According to estimates, more than 5 million lives are saved annually by the implementation of six standard vaccines, including diphtheria, hepatitis B, Haemophilus influenza type b, polio, tetanus and yellow fever. Despite these efforts, we are faced with challenges in developing countries where increasing population and increasing disease burden and difficulties in vaccine coverage and delivery cause significant morbidity and mortality. Additionally, the high cost of these vaccines is also one of the causes for inappropriate and inadequate vaccinations in these regions. Thus, developing cost-effective vaccine strategies that could provide a stronger immune response with reduced vaccination schedules and maximum coverage is of critical importance. In last decade, different approaches have been investigated; among which live bacterial vaccines have been the focus of attention. In this regard, probiotic lactic acid bacteria have been extensively studied as safe and effective vaccine candidates. These microorganisms represent the largest group of probiotic bacteria in the intestine and are generally recognised as safe (GRAS) bacteria. They have also attracted attention due to their immunomodulatory actions and their effective role as novel vaccine adjuvants. A significant property of these bacteria is their ability to mimic natural infections, while intrinsically possessing mucosal adjuvant properties. Additionally, as live bacterial vaccines are administered orally or nasally, they have higher acceptance and better safety, but also avoid the risk of contamination due to needles and syringes. In this review, we emphasise the role of probiotic Lactobacillus strains as putative oral vaccine carriers and novel vaccine adjuvants.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 898 | 665 | 97 |
| Full Text Views | 26 | 10 | 1 |
| PDF Views & Downloads | 33 | 15 | 0 |
